Finance

Lists
AKUMS:NSE
Akums Drugs and Pharmaceuticals Ltd
₹724.80
-3.60%
(-27.05) 1D
Aug 14, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AKUMS...
Open
₹748.15
High
₹763.25
Low
₹724.80
Mkt. cap
111.60B
Avg. vol.
0.00
Volume
184.80K
Dividend
0.14%
Quarterly dividend
₹0.25
Ex-dividend date
Jul 3, 2026
P/E ratio
38.05
52-wk high
₹775.00
52-wk low
₹409.30
EPS
₹19.05
No. of employees
7K
Open
₹748.15
High
₹763.25
Low
₹724.80
Mkt. cap
111.60B
Avg. vol.
0.00
Volume
184.80K
Dividend
0.14%
Quarterly dividend
₹0.25
Ex-dividend date
Jul 3, 2026
P/E ratio
38.05
52-wk high
₹775.00
52-wk low
₹409.30
EPS
₹19.05
No. of employees
7K
News stories
From web sources and news partners
Profile
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024. Wikipedia
About Akums Drugs and Pharmaceuticals Ltd
CEO-
Employees7.34K
Founded2004
Headquarters-
SectorHealth care
Websiteakums.in
Last report
Aug 10, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹6.53 / ₹6.10
+7.05%beat
Revenue / Est. (INR)
11.67B / 11.65B
+0.14%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
10.18B
11.60B
11.60B
11.67B
Cost of goods sold
5.93B
6.79B
7.37B
6.45B
Cost of revenue
5.93B
6.79B
7.37B
6.45B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.89B
1.89B
2.37B
2.01B
Operating expense
3.68B
3.74B
3.09B
3.88B
Total operating expenses
9.61B
10.52B
10.46B
10.33B
Operating income
566.12M
1.07B
1.14B
1.34B
Other non operating income
323.65M
343.28M
-942.12M
303.80M
EBT including unusual items
656.73M
995.66M
1.21B
1.39B
EBT excluding unusual items
656.73M
1.18B
1.19B
1.39B
Income tax expense
229.77M
318.92M
398.74M
382.59M
Effective tax rate
34.99%
32.03%
32.89%
27.48%
Other operating expenses
1.41B
1.45B
319.86M
1.45B
Net income
407.83M
663.17M
846.13M
1.00B
Net profit margin
4.01%
5.72%
7.29%
8.57%
Earnings per share
2.66
5.14
-
6.53
Interest and investment income
-
-
1.10B
-
Interest expense
-233.04M
-237.42M
-184.41M
-247.56M
Net interest expenses
-233.04M
-237.42M
912.36M
-247.56M
Depreciation and amortization charges
378.64M
396.49M
401.18M
410.65M
EBITDA
940.04M
1.42B
1.49B
1.69B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps